Last updated at 02 Jul 2024 12:48 PM
Director
DIN: 09240577
Ankit Satish Shah is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at GRATILA HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09240577.Ankit Satish Shah is currently involved in 2 different roles. Their most recent position is with GRATILA CANCER FOUNDATION as a Individual Promoter. The first company Ankit Satish Shah was appointed to as a director was GRATILA HEALTHCARE PRIVATE LIMITED. Ankit Satish Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ankit Satish Shah is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at GRATILA HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09240577.Ankit Satish Shah is currently involved in 2 different roles. Their most recent position is with GRATILA CANCER FOUNDATION as a Individual Promoter. The first company Ankit Satish Shah was appointed to as a director was GRATILA HEALTHCARE PRIVATE LIMITED. Ankit Satish Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GRATILA HEALTHCARE PRIVATE LIMITED | Director | 15-Jul-2021 |
| GRATILA HEALTHCARE PRIVATE LIMITED | Individual Promoter | 15-Jul-2021 |
| GRATILA CANCER FOUNDATION | Individual Promoter | 26-Nov-2021 |
| GRATILA CANCER FOUNDATION | Director | 26-Nov-2021 |